These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 15585113)
1. Factors influencing the titer and infectivity of lentiviral vectors. Logan AC; Nightingale SJ; Haas DL; Cho GJ; Pepper KA; Kohn DB Hum Gene Ther; 2004 Oct; 15(10):976-88. PubMed ID: 15585113 [TBL] [Abstract][Full Text] [Related]
2. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors. Bell AJ; Fegen D; Ward M; Bank A Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083 [TBL] [Abstract][Full Text] [Related]
3. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Haas DL; Case SS; Crooks GM; Kohn DB Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830 [TBL] [Abstract][Full Text] [Related]
4. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847 [TBL] [Abstract][Full Text] [Related]
5. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055 [TBL] [Abstract][Full Text] [Related]
6. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950 [TBL] [Abstract][Full Text] [Related]
7. A new-generation stable inducible packaging cell line for lentiviral vectors. Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062 [TBL] [Abstract][Full Text] [Related]
8. Production of lentiviral vectors for transducing cells from the central nervous system. Li M; Husic N; Lin Y; Snider BJ J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962 [TBL] [Abstract][Full Text] [Related]
9. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells. Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949 [TBL] [Abstract][Full Text] [Related]
10. Systematic determination of the packaging limit of lentiviral vectors. Kumar M; Keller B; Makalou N; Sutton RE Hum Gene Ther; 2001 Oct; 12(15):1893-905. PubMed ID: 11589831 [TBL] [Abstract][Full Text] [Related]
11. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904 [TBL] [Abstract][Full Text] [Related]
12. Optimized large-scale production of high titer lentivirus vector pseudotypes. Sena-Esteves M; Tebbets JC; Steffens S; Crombleholme T; Flake AW J Virol Methods; 2004 Dec; 122(2):131-9. PubMed ID: 15542136 [TBL] [Abstract][Full Text] [Related]
14. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems. Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669 [TBL] [Abstract][Full Text] [Related]
15. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192 [TBL] [Abstract][Full Text] [Related]
16. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Klages N; Zufferey R; Trono D Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945 [TBL] [Abstract][Full Text] [Related]
17. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. Akkina RK; Walton RM; Chen ML; Li QX; Planelles V; Chen IS J Virol; 1996 Apr; 70(4):2581-5. PubMed ID: 8642689 [TBL] [Abstract][Full Text] [Related]
18. Neuron-specific gene transfer through retrograde transport of lentiviral vector pseudotyped with a novel type of fusion envelope glycoprotein. Kato S; Kuramochi M; Takasumi K; Kobayashi K; Inoue K; Takahara D; Hitoshi S; Ikenaka K; Shimada T; Takada M; Kobayashi K Hum Gene Ther; 2011 Dec; 22(12):1511-23. PubMed ID: 21806473 [TBL] [Abstract][Full Text] [Related]
19. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. Zhang XY; La Russa VF; Reiser J J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277 [TBL] [Abstract][Full Text] [Related]
20. Quantification of HIV-based lentiviral vectors: influence of several cell type parameters on vector infectivity. Gay V; Moreau K; Hong SS; Ronfort C Arch Virol; 2012 Feb; 157(2):217-23. PubMed ID: 22042211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]